O-306 LINZAGOLIX FOR ENDOMETRIOSIS-ASSOCIATED PAIN: SAFETY RESULTS FROM EDELWEISS 3, A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Author(s) -
J. Donnez,
H. Taylor,
Kristina GemzellDanielsson,
William H. Catherino,
Elke Bestel,
JeanPierre Gotteland,
Andrew Humberstone,
L Moore,
E Garner
Publication year - 2022
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/deac105.103
Subject(s) - placebo , tolerability , medicine , adverse effect , randomized controlled trial , endometriosis , anesthesia , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom